UBS Group
MEDP icon

UBS Group’s Medpace MEDP Stock Holding History

UBS Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$28K – 9293
2020
Q4 		$28K Hold
200
– – ﹤0.01% 6692
2020
Q3 		$22K Hold
200
– – ﹤0.01% 6239
2020
Q2 		$19K Sell
200
-100
-33% -$8.51K ﹤0.01% 6590
2020
Q1 		$22K Sell
300
-200
-40% -$17.4K ﹤0.01% 6436
2019
Q4 		$42K Buy
+500
New +$38.7K ﹤0.01% 6448

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

UBS Group's MEDP Position: Q2 2026 in Review

UBS Group reduced its Medpace (MEDP) stake by 11% in Q2 2026, selling an estimated $16.8M and leaving 303,926 shares worth $161M. The position accounts for 0.02% of the portfolio, ranked #795.

UBS Group first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $185M in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • UBS Group held 303,926 shares of Medpace worth $161M as of Q2 2026.
  • UBS Group sold 36,507 Medpace shares in Q2 2026, an estimated $16.8M.
  • Medpace made up 0.02% of UBS Group's portfolio in Q2 2026, its #795 holding.
  • UBS Group first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
  • UBS Group's Medpace position peaked at $185M in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.